Acute bronchiolitis remains the most common reason for hospitalization of infants worldwide. Bronchiolitis typically affects children younger than two years with a peak incidence between two and six months of age. This article discusses few important clinical practice guidelines for treatment of pediatric bronchiolitis. The management of bronchiolitis is a controversial issue.
There is no definitive antiviral therapy for most causes of bronchiolitis, management of these infants involves symptomatic relief and maintenance of hydration and oxygenation. There is little evidence to support the use of pharmacological agents in managing of bronchiolitis. Therefore, NICE (National Institute for Health and Care Excellence) and AAP (American Academy of Pediatrics) clinical practice do’s and don’ts for pediatric bronchiolitis are discussed briefly below. Do’s Give oxygen supplementation if their…
